By Dr Jia (Jenny) Liu

Journal articles

Liu JJ; He S; Butow P; Shaw J; McHardy CJ; Harris G; Serafimovska A; Butt Z; Beith JM, 2023, 'Implementation study of a novel brief clinician intervention to reduce fear of recurrence in cancer survivors (CIFeR_2 Implementation Study).', Journal of Clinical Oncology, 41, pp. e24183 - e24183, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e24183

Boys E; Liu JJ; Cai Z; Noor Z; Mackenzie KL; Aref A; Sykes E; Xavier D; Lucas N; Williams S; Bucio-Noble D; Koh J; Hains P; Robinson PJ; Zhong Q; Reddel RR, 2023, 'Pan-cancer diagnostic proteomic signature of tissue-of-origin (TOO) using data-independent acquisition mass spectrometry (DIA-MS) from 1289 human tissue samples.', Journal of Clinical Oncology, 41, pp. 3120 - 3120, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.3120

Nindra U; Hurwitz J; Forstner D; Chin V; Gallagher R; Liu J, 2023, 'A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma', Cancer Medicine, 12, pp. 11234 - 11247, http://dx.doi.org/10.1002/cam4.5815

Schram AM; Subbiah V; Sullivan R; Cosman R; Liu J; Sbar EI; Hoang T; Chen J; Johnson M; Amoruccio V; Shearer T; Kamal A; Lewis J; Shao W; Edris B; Luo L; Desai J, 2023, 'Abstract CT031: A first-in-human, phase 1a/1b, open-label, dose-escalation and expansion study to investigate the safety, pharmacokinetics, and antitumor activity of the RAF dimer inhibitor BGB-3245 in patients with advanced or refractory tumors', Cancer Research, 83, pp. ct031 - ct031, http://dx.doi.org/10.1158/1538-7445.am2023-ct031

Kamath S; Tai D; Moreno I; Babiker H; Jin Z; Yoo C; Ricard F; Jen KY; Coward J; Liu J; Opdam F; Millward M; Ponz-Sarvise M; Yachnin J; Kim R; Park JO; Subbiah V; Schram AM, 2023, 'Abstract OT3-24-01: ReFocus: A Phase 1/2 Study of the Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients with Advanced Solid Tumors Including Breast Cancer', Cancer Research, 83, pp. ot3-24-01-ot3-24-01, http://dx.doi.org/10.1158/1538-7445.sabcs22-ot3-24-01

Pham JP; Sivasubramaniam V; Gallagher R; Forstner D; Wong M; Liu J, 2023, 'Safety of cemiplimab for advanced cutaneous squamous cell carcinoma in a patient with p-ANCA-associated vasculitis', Journal of the European Academy of Dermatology and Venereology, 37, pp. e363 - e365, http://dx.doi.org/10.1111/jdv.18649

Boys EL; Liu J; Robinson PJ; Reddel RR, 2023, 'Clinical applications of mass spectrometry‐based proteomics in cancer: Where are we?', PROTEOMICS, 23, pp. e2200238 - e2200238, http://dx.doi.org/10.1002/pmic.202200238

Jones RH; Pinato DJ; Joshua A; Forster MD; Morton C; Aboud K; Liu JJ; Fulgenzi C; Kefas J; Edmondson S; Main NJ; Paull JRA; Fairley JK; Spicer J, 2022, '1403P Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (CTX-SPL9111) in men with metastatic castration-resistant prostate cancer (mCRPC) in a phase I/II trial', Annals of Oncology, 33, pp. s1186 - s1187, http://dx.doi.org/10.1016/j.annonc.2022.07.1889

Cai Z; Poulos RC; Liu J; Zhong Q, 2022, 'Machine learning for multi-omics data integration in cancer', iScience, 25, pp. 103798 - 103798, http://dx.doi.org/10.1016/j.isci.2022.103798

Serafimovska A; Liu J; Beith J; Butow P, 2021, 'Patients’ and oncologists’ perspectives on a novel Clinician-led Fear of Cancer Recurrence (CIFeR) Intervention', Supportive Care in Cancer, 29, pp. 7637 - 7646, http://dx.doi.org/10.1007/s00520-021-06336-0

Liu J; Butow P; Bui KT; Serafimovska A; Costa DSJ; Kiely BE; Hui MN; Goodwin A; McNeil CM; Beith JM, 2021, 'Novel Clinician-Lead Intervention to Address Fear of Cancer Recurrence in Breast Cancer Survivors', JCO Oncology Practice, 17, pp. E774 - E784, http://dx.doi.org/10.1200/OP.20.00799

Liu J; Itchins M; Nagrial A; Cooper WA; De Silva M; Barnet M; Varikatt W; Sivasubramaniam V; Davis A; Gill AJ; Blinman P; Lee K; Hui R; Gao B; Pavlakis N; Clarke S; Lee J; Boyer M; Kao S, 2021, 'Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitors', Lung Cancer, 155, pp. 28 - 33, http://dx.doi.org/10.1016/j.lungcan.2021.03.004

Liu J; Itchins M; Nagrial A; Cooper W; De Silva M; Barnet M; Varikatt W; Sivasubramaniam V; Davis A; Gill A; Blinman P; Lee K; Hui R; Gao B; Pavlakis N; Clarke S; Lee J; Boyer M; Kao S, 2021, 'P76.08 High Tumour PD-L1 Is Associated With Poor Outcomes in EGFR-Mutant Lung Cancer Treated With First Generation EGFR TKIs', Journal of Thoracic Oncology, 16, pp. s588 - s589, http://dx.doi.org/10.1016/j.jtho.2021.01.1065

Liu J; Goel S; Beith JMN, 2020, 'Trastuzumab-related cardiotoxicity: What do we know in 2020?', Translational Cancer Research, 9, pp. 4052 - 4055, http://dx.doi.org/10.21037/tcr-20-2188

Liu J; Wong K; Patanjali N; Boyer M; Kao S, 2020, 'Case of post-progression prolongation of survival after cessation of pembrolizumab in advanced non-small-cell lung cancer', Internal Medicine Journal, 50, pp. 771 - 773, http://dx.doi.org/10.1111/imj.14852

Liu J; Bui KT; Serafimovska A; Kiely BE; Hui MN; Goodwin A; McNeil CM; Costa DS; Butow P; Beith JM, 2020, 'CIFeR: A novel Clinician-lead Intervention to address Fear of cancer Recurrence (FCR) in breast cancer survivors.', Journal of Clinical Oncology, 38, pp. 12115 - 12115, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.12115

Liu J; Butow P; Beith J, 2019, 'Systematic review of interventions by non-mental health specialists for managing fear of cancer recurrence in adult cancer survivors', Supportive Care in Cancer, 27, pp. 4055 - 4067, http://dx.doi.org/10.1007/s00520-019-04979-8

Goel S; Liu J; Guo H; Barry W; Bell R; Murray B; Lynch J; Bastick P; Chantrill L; Kiely BE; Abdi E; Rutovitz J; Asghari R; Sullivan A; Harrison M; Kohonen-Corish M; Beith J, 2019, 'Decline in Left Ventricular Ejection Fraction Following Anthracyclines Predicts Trastuzumab Cardiotoxicity', Jacc Heart Failure, 7, pp. 795 - 804, http://dx.doi.org/10.1016/j.jchf.2019.04.014

Crabtree N; Mo S; Ong L; Jegathees T; Wei D; Fahey D; Liu JJ, 2017, 'Retrospective Analysis of Patient Presentations at the Sydney (Australia) Royal Easter Show from 2012 to 2014', Prehospital and Disaster Medicine, 32, pp. 187 - 194, http://dx.doi.org/10.1017/S1049023X16001540

Youngson N; Lecomte V; Maloney C; Leung P; Liu J; Hesson L; Luciani F; Krause L; Morris M; Liu JJ, 2016, 'Obesity-induced sperm DNA methylation changes at satellite repeats are reprogrammed in rat offspring', Asian Journal of Andrology, 18, pp. 930 - 936, http://dx.doi.org/10.4103/1008-682X.163190

Liu J; Hau E; Links M; Graham PH, 2016, 'Adenoid cystic carcinoma of the lung: Response to tamoxifen after chemoradiation', Asia Pacific Journal of Clinical Oncology, 12, pp. e352 - e355, http://dx.doi.org/10.1111/ajco.12184

Liu J; Ng D; Lee J; Stalley P; Hong A, 2016, 'Chest wall desmoid tumours treated with definitive radiotherapy: A plan comparison of 3D conformal radiotherapy, intensity-modulated radiotherapy and volumetric-modulated arc radiotherapy', Radiation Oncology, 11, http://dx.doi.org/10.1186/s13014-016-0611-0

Thoms JAI; Knezevic K; Liu JJ; Glaros EN; Thai T; Qiao Q; Campbell H; Packham D; Huang Y; Papathanasiou P; Tunningley R; Whittle B; Yeung AWS; Chandrakanthan V; Hesson L; Chen V; Wong JWH; Purton LE; Ward RL; Thomas SR; Pimanda JE, 2016, 'Arrested hematopoiesis and vascular relaxation defects in mice with a mutation in Dhfr', Molecular and Cellular Biology, 36, pp. 1222 - 1236, http://dx.doi.org/10.1128/MCB.01035-15

Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A, 2015, 'Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma', Annals of Surgical Oncology, 22, pp. 1893 - 1900, http://dx.doi.org/10.1245/s10434-014-4237-x

Simar D; Versteyhe S; Donkin I; Liu J; Hesson L; Nylander V; Fossum A; Barrès R, 2014, 'DNA methylation is altered in B and NK lymphocytes in obese and type 2 diabetic human.', Metabolism, 63, pp. 1188 - 1197, http://dx.doi.org/10.1016/j.metabol.2014.05.014

Liu J; Hesson LB; Ward RL, 2013, 'Liquid chromatography tandem mass spectrometry for the measurement of global DNA methylation and hydroxymethylation', Journal of Proteomics & Bioinformatics, 01, http://dx.doi.org/10.4172/jpb.S2-005

Hesson LB; Patil V; Sloane MA; Nunez AC; Liu J; Pimanda JE; Ward RL, 2013, 'Reassembly of nucleosomes at the MLH1 promoter initiates resilencing following decitabine exposure.', PLoS Genet, 9, pp. e1003636, http://dx.doi.org/10.1371/journal.pgen.1003636

Liu J; Hesson LB; Meagher AP; Bourke MJ; Hawkins NJ; Rand KN; Molloy PL; Pimanda JE; Ward RL, 2012, 'Relative distribution of folate species is associated with global DNA methylation in human colorectal mucosa', Cancer Prevention Research, 5, pp. 921 - 929, http://dx.doi.org/10.1158/1940-6207.CAPR-11-0577

Liu JJ; Hesson LB; Rand KN; Molloy PL; Pimanda J; Ward RL, 2011, 'Abstract 91: Analysis of global and repeat sequence DNA methylation in the blood and normal colonic mucosa of colorectal cancer patients, healthy individuals and patients with folate deficiency', Cancer Research, 71, pp. 91 - 91, http://dx.doi.org/10.1158/1538-7445.am2011-91

Liu J; Pickford R; Meagher AP; Ward RL, 2011, 'Quantitative analysis of tissue folate using ultra-high performance liquid chromatography tandem mass spectrometry', Analytical Biochemistry, 411, pp. 210 - 217, http://dx.doi.org/10.1016/j.ab.2010.12.033

Liu J; Ward RL, 2010, 'Folate and one-carbon metabolism and its impact on aberrant DNA methylation in cancer', Advances in Genetics, 71, pp. 80 - 121, http://dx.doi.org/10.1016/B978-0-12-380864-6.00004-3

Conference Papers

Lemech CR; Humphries TG; Kichenadasse G; Richardson GE; Nagrial A; Teng C; Liu J; Joshua A; Yeo B; Cohen H; Bray C; Wang Y; Mo J; Harvey K; Zhang H; Ling Z; King N; Chal J; Ding J; Cioffi M; Maurer M; Hofmeister RJ; Getts D; Swarbrick A; Cosman R, 2025, '1342 First-in-human dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and initial efficacy of mRNA-LNP MT-302 in vivo CAR therapy in solid tumors', BMJ, pp. a1583 - a1583, presented at Late-Breaking Abstracts, http://dx.doi.org/10.1136/jitc-2025-sitc2025.1342

Liu JJ; Kichenadasse G; Guerrero TCH; Calvo E; Gan HK; Markman B; Garcia VM; Symeonides SN; Meyer T; Mirallas O; Thistlethwaite F; Ottensmeier CHH; Pinato DJ; Giovannetti M; Green D; Hyland N; Joyce PI; McAlpine C; Palmer T; Lillie THW, 2025, '1561P EMITT-1: Final clinical, PK & PD data from dose escalation and selection of recommended dose for expansion cohorts in a phase I study of GRWD5769 (a first-in-class ERAP1i) in patients with solid malignancies', in Annals of Oncology, Elsevier, pp. s931 - s932, http://dx.doi.org/10.1016/j.annonc.2025.08.2191

Liu JJ; Tebbutt N; Price TJ; Alasady R; Hsu E; Shafren D; Zdanska O; Wong M, 2025, '882eP Phase I study of intratumoural (IT) IVX037, a novel CD55-targeted oncolytic RNA virus, in advanced microsatellite stable (MSS) colorectal cancer (CRC): Serum biomarkers, viral kinetics, and KRAS mutation analysis', in Annals of Oncology, Elsevier, pp. s584, http://dx.doi.org/10.1016/j.annonc.2025.08.1453

Yu X; Zhang J; Liu JJ; Yang J; Yue J; Sun Y; Pan Y; Sun ML; Qin Y; Shen L; Song R; Ruan J; Zhou A; Mou Y; Aghmesheh M; Morris M; Yu X; Zhao X; Chen M; Tazbirkova A, 2024, '132MO Anti-claudin18.2 (CLDN18.2) antibody-drug conjugate (ADC) IBI343 in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC): Updated results from a phase I study', in Annals of Oncology, Elsevier, pp. s1456, http://dx.doi.org/10.1016/j.annonc.2024.10.158

Liu JJ; Yu X; Zhang J; Yang J; Yue J; Sun Y; Pan Y; Sun M; Qin Y; Shen L; Song R; Ruan J; Zhou A; Mou Y; Liu Z; Liu Z; Morris M; Aghmesheh M; Tazbirkova A; Zhou H, 2024, '396MO Anti-claudin 18.2 (CLDN18.2) antibody-drug conjugate (ADC) IBI343 in patients (pts) with solid tumors and gastric/gastro-esophageal junction adenocarcinoma (G/GEJ AC): A phase I study', in Annals of Oncology, Elsevier, pp. s160, http://dx.doi.org/10.1016/j.annonc.2024.05.311

Liu JJ; He S; Butow P; Shaw J; McHardy CJ; Harris G; Serafimovska A; Butt Z; Beith JM, 2023, 'Implementation study of a novel brief clinician intervention to reduce fear of recurrence in cancer survivors (CIFeR_2 Implementation Study).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023

Liu J; Price T; Tebbutt N; Hsu E; Al-Asady R; Shafren DR; Croll N; Wong M, 2023, '649 Phase 1a open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 in patients with advanced microsatellite stable (MSS) colorectal, gastroesophageal or ovarian cancer', BMJ, pp. a740 - a740, presented at Regular and Young Investigator Award Abstracts, http://dx.doi.org/10.1136/jitc-2023-sitc2023.0649

Liu J; Bui KT; Serafimovska A; Kialy BE; Hui MN; Goodwin A; McNeil CM; Costa DSJ; Butow P; Beith JM, 2020, 'CIFeR: A novel Clinician-lead Intervention to address Fear of cancer Recurrence (FCR) in breast cancer survivors.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020

Patil V; Sloane MA; Wong JW; Liu J; Ward RL; Hesson LB, 2013, 'Abstract 2983: Gene resilencing following decitabine therapy is initiated by nucleosome reoccupancy and is related to CpG island shore methylation.', in Cancer Research, American Association for Cancer Research (AACR), pp. 2983 - 2983, http://dx.doi.org/10.1158/1538-7445.am2013-2983

Conference Presentations

Peng J; Liu JJ; Daniels B; Firriolo J; Laaksonen MA; Hawkins NJ; Meagher AP; Hayes I; Croxford M; Cai S; Ward RL, 2014, 'RETROSPECTIVE COMPARISON OF RECTAL CANCER TREATMENT IN CHINA AND AUSTRALIA FROM 1995-2012', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345350900095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Thistlethwaite F; Roda D; Alvarez EC; Moreno V; Guerrero TH; García-Corbacho J; Liu J; Jain VK; Calvo E; Korakis I; Ouali K; De La Motte Rouge T; Plummer R; Ottensmeier CHH; Cassier PA; Symeonides SN; Hyland N; McAlpine C; Palmer T; Lillie T, 2026, 'EMITT-1: Clinical and pharmacodynamic activity with the oral ERAP1 inhibitor GRWD5769 and cemiplimab in 6 completed phase 1b expansion cohorts in solid tumors with anti–PD-1 resistance or MSS-CRC.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 44, pp. 2500 - 2500, http://dx.doi.org/10.1200/jco.2026.44.16_suppl.2500

Liu J; Cosman R; Childs S; Cohen JE; Rodrigues A; Hansen T; Kiely BE; Chen J; Pala A; Sandhu G; Ho J; Warakulasuriya S; Elgundi D; Sim H-W; Kent R; Martin C; Woodson EM; Chaffer CL; Dear R, 2026, 'Abstract CT043: Androgen receptor inhibition to overcome taxane resistance in AR-positive metastatic TNBC: Interim results of the 4CAST Phase 1b trial', in Cancer Research, American Association for Cancer Research (AACR), Vol. 86, pp. ct043 - ct043, http://dx.doi.org/10.1158/1538-7445.am2026-ct043

Tarhini AA; Chen M; Liu J; Monga V; Atkinson V; Piha-Paul SA; Chmielowski B; Herzberg B; Lemech C; Bhave P; Kichenadasse G; Falchook G; Mehnert J; Vandross A; Salkeni M; McKean M; Wages D; Kennedy AM; Ryan MB; Clark J; Nanah A; Fossler MJ; Komarnitsky P; Puzanov I, 2026, 'Abstract CT129: Preliminary results from a Phase 1a/b dose-escalation and expansion trial of the pan-RAF-MEK molecular glue NST-628 in patients (pts) with advanced or refractory RAF, KRAS, and NRAS-mutant solid tumors', in Cancer Research, American Association for Cancer Research (AACR), Vol. 86, pp. ct129 - ct129, http://dx.doi.org/10.1158/1538-7445.am2026-ct129

Liu J; Frentzas S; Kichenadasse G; Price T; Tebbutt N; Mendis S; Al-Asady R; Hsu E; Chan M; Tran P; Shafren D; Zdanska O; Wong M, 2026, 'Abstract CT183: Phase Ib clinical evaluation of a novel CD55- and FcRn-bioselected RNA oncolytic virus, IVX037, combined with sintilimab (anti-PD-1) in advanced microsatellite-stable colorectal cancer', in Cancer Research, American Association for Cancer Research (AACR), Vol. 86, pp. ct183 - ct183, http://dx.doi.org/10.1158/1538-7445.am2026-ct183

Hollebecque A; Borad MJ; Lu P; Meng X; Ryan K; Alexander L; Liu J; Oh D-Y; Kim RD, 2026, 'Efficacy and safety of lirafugratinib in FGFRi-naïve cholangiocarcinoma (CCA) patients harboring FGFR2 fusions/rearrangements (FGFR2 f/r).', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 44, pp. 476 - 476, http://dx.doi.org/10.1200/jco.2026.44.2_suppl.476

Hall A; Crumbaker M; Pham J; Liu J; Sim HW; Joshua AM, 2024, 'A meta-analysis of overall survival and response in metastatic adrenocortical carcinoma: A review of 23 prospective trials of 880 patients.', in Journal of Clinical Oncology, Vol. 42, pp. 4 - 4, http://dx.doi.org/10.1200/JCO.2024.42.4_suppl.4

Pinato DJ; Jones RH; Forster MD; Joshua AM; Korolewicz J; Benafif S; Aboud K; Liu JJ; Cosman R; Paull J; Fairley J; Edmondson SR; Spicer JF, 2024, 'Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (CTX-SPL9111) in advanced esophagogastric cancers in a phase 1/2 trial', in Journal of Clinical Oncology, Vol. 42, http://dx.doi.org/10.1200/JCO.2024.42.3_suppl.374

Hurwitz J; Nindra U; Liu J, 2022, 'Systematic review of neoadjuvant and definitive immunotherapy in head and neck squamous cell carcinoma', in Asia-Pacific Journal of Clinical Oncology, Wiley, Vol. 18, pp. 38 - 38, presented at Medical Oncology Group of Australia Incorporated Annual Scientific Meeting 2022, https://doi.org/10.1111/ajco.13856

Zdanska O; Zdansky P; Liu J; Joshua A; Stanners M; Rogers C, 2022, 'Patient experiences of prolonged living with cancer during early phase trial treatment', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 147 - 147

Back to profile page